ID   MRL/N-1/TARC-AT,
AC   CVCL_D5J8
DR   Wikidata; Q127382887
RX   PubMed=13130475;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1329039; Ccl17 (Note=With p.Met1_Val29del and p.Gly30Met = TARC-Antagonist).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MRL/Mp Tn-gld/gld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5J6 ! MRL/N-1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=13130475; DOI=10.1002/art.11231;
RA   Hasegawa H., Kohno M., Sasaki M., Inoue A., Ito M.R., Terada M.,
RA   Hieshima K., Maruyama H., Miyazaki J.-i., Yoshie O., Nose M., Fujita S.;
RT   "Antagonist of monocyte chemoattractant protein 1 ameliorates the
RT   initiation and progression of lupus nephritis and renal vasculitis in
RT   MRL/lpr mice.";
RL   Arthritis Rheum. 48:2555-2566(2003).
//